Article

RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression

bioRxiv · 2023 · Augusto Bleve

Key facts

Title RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression
First author Augusto Bleve
Journal bioRxiv
Published Nov 19, 2023
DOI 10.1101/2023.11.19.567414
Devices mentioned K202641, K231013, K772215, K935809, K951821
Product codes mentioned CGI, GQH, LIN, QBD, JJH, LBS, MVU, PFF, PFT, PPM

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature